International Conference on Innovations for the Elimination and Control of Visceral Leishmaniasis (IEC-VL)

28-30 November 2018 
New Delhi, India

The major objective of the International Conference on Innovations for the Elimination and Control of Visceral Leishmaniasis (IEC-VL) is to bring together leading scientists from academia and industry around the world to deliberate upon new tools, new approaches, and routes to implementation.

 

Session

VL & PKDL– Current status from control to elimination

Date: Wednesday, 28 November 2018
Time: 11:00-12:20

Chair: Simon Croft, Professor of Parasitology, London School of Hygiene and Tropical Medicine, UK
Co-chair: Shyam Sundar, Medical field, Banaras Hindu University, Varanasi, UP, India

Elimination of kala-azar in the Indian subcontinent: Lessons from elimination of other neglected diseases
Suman Rijal, Head of Regional Office, DNDi India

A path achieved towards kala-azar near-elimination in Bangladesh
Rajib Chowdhury, National Institute of Preventive and Social Medicine, Bangladesh

Overview of VL in India, past and present
Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India

PKDL a threat in kala-azar elimination strategy in Indian Subcontinent
Ed Zijlstra, Senior Consultant, DNDi 

 

Epidemiology

Date: Wednesday, 28 November 2018
Time: 15:40-16:40

Chair: Nupur Roy, Additional Director, National Vector Borne Disease Control Program, India
Co-chair: Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland

The pattern of diagnosed cases in time and space during elimination and postelimination of VL in India
Graham Medley, Professor, London School of Hygiene and Tropical Medicine, UK

Determinants of disease progression and role of asymptomatic Leishmania donovani infection in transmission
Om Prakash Singh, Scientist at Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India

Leishmania donovani variant that causes cutaneous leishmaniasis in Sri Lanka
Nadira Karunaweera, Chair and Professor of Parasitology, Colombo University, Sri Lanka

 

 

Transmission

Date: Wednesday, 28 November 2018
Time: 17:20-18:20

Chair: Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India
Co-chair: Mary Cameron, Professor, London School of Hygiene and Tropical Medicine, UK

Significance of vector challenge in relation to visceral leishmaniasis control: deciphering sand fly-transmitted infections
Shaden Kamhawi, The National Institute of Allergy and Infectious Diseases, NIH, USA

The role of PKDL patients in the VL transmission in Bangladesh
Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland

When to stop Indoor Residual Spray for Kala- azar elimination
R. K. Dasgupta, Ex. Joint Director, National Vector Borne Disease Control Program, India

 

Drugs

Date: Thursday, 29 November 2018
Time: 8:30-9:50

Chair: Syamal Roy, Indian Institute of Chemical Biology, India
Co-chair: Dan Zilberstein, Professor of Microbiology at the Faculty of Biology, Technion, Israel Institute of Technology, Israel

Drug discovery to combat VL in India
Neena Goel, Central Drug Research Institute, India

Current and future perspectives for the development of innovative treatments for leishmaniasis
Fabiana Alves, Head of Visceral Leishmaniasis Clinical Program, DNDi, Switzerland

Therapeutic role of cholesterol in experimental visceral leishmaniasis
Syamal Roy, Indian Institute of Chemical Biology, India

PK/PD as a tool for the development and optimization of new therapies for VL
Thomas Dorlo, The Netherlands Cancer Institute, Amsterdam, Netherlands, and DNDi Consultant

 

Diagnostics

Date: Thursday, 29 November 2018
Time: 10:10-11:10

Chair: Suman Rijal, Head of Regional Office, DNDi India
Co-chair: Greg Matlashewski, Interim Chair and Professor, McGill University, Canada

Post kala-azar dermal leishmaniasis (PKDL): challenges in diagnosis and treatment
Poonam Salotra, Deputy Director, National Institute of Pathology, India

Diagnosis and management of VL-HIV coinfection within the elimination framework
Sakib Burza, Medical Advisor Asia, Médecins Sans Frontières, India

Unmet diagnostic needs in leishmaniasis
Isra Cruz, Senior Scientific Officer, FIND, Switzerland

 

 

Panel Discussion

Innovations in communications and advocacy needed to sustain the elimination of VL

Date: Thursday, 29 November 2018
Time: 11:10-12:00

Chairs:

  • P.K. Sen, Director, National Vector Borne Disease Control Program, India
  • N.K. Ganguly, Former DG, Indian Council of Medical Research, India

Speakers:

  • Amresh Kumar, Team Leader/Senior Medical Officer, PATH, New Delhi, India
  • M.P. Sharma, Additional Director cum SPO, Bihar
  • Mary Cameron, Professor, London School of Hygiene and Tropical Medicine, UK
  • Amandeep Singh, Director, Global Health Strategies, India
  • Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India
  • Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland

 

Key outcomes, position paper on research needs and opportunities to sustain VL elimination

Date: Thursday, 29 November 2018
Time: 16:40-18:00

Chairs:

  • Piero Olliaro, Centre for Tropical Diseases and Global Health Nuffield Department of Medicine, University of Oxford, UK
  • N.K. Ganguly, Former DG, Indian Council of Medical Research, India
  • Simon Croft, Professor of Parasitology, London School of Hygiene and Tropical Medicine, UK

Speakers:

  • R. K. Das Gupta, Ex. Joint Director, National Vector Borne Disease Control Program, India
  • Hira Nakhasi, FDA, USA
  • Sakib Burza, Medical Advisor Asia, Médecins Sans Frontières, India
  • Saurabh Jain, Technical officer for vector borne and neglected tropical diseases, WHO, Switzerland
  • Suman Rijal, Head of Regional Office, DNDi India
  • William Starbuck, Senior Program Officer, Visceral Leishmaniasis, Bill & Melinda Gates Foundation, India

 

 

More information: